Bone mineral density is not significantly reduced in adult patients on low-dose glucocorticoid replacement therapy

Journal of Clinical Endocrinology and Metabolism

Volumn 97, Issue 1, 2012, Pages 85-92

  Koetz, K R ^a   Ventz, M ^a   Diederich, S ^b   Quinkler, Marcus ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b Endokrinologikum   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; COLLAGEN; DEXAMETHASONE; FLUDROCORTISONE; GLUCOCORTICOID; HORMONE; HYDROCORTISONE; MINERAL; MINERALOCORTICOID; ORAL CONTRACEPTIVE AGENT; OSTEOCALCIN; PRASTERONE; PREDNISOLONE; SEX HORMONE; VITAMIN; VITAMIN D;

ADRENAL INSUFFICIENCY; ADULT; AGED; ARTICLE; BONE; BONE DENSITY; BONE TURNOVER; COHORT ANALYSIS; COMBINATION CHEMOTHERAPY; CONGENITAL ADRENAL HYPERPLASIA; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DRUG ACTIVITY; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; FEMUR NECK; HORMONE BLOOD LEVEL; HORMONE SUBSTITUTION; HUMAN; LOW DRUG DOSE; LUMBAR SPINE; MAJOR CLINICAL STUDY; MALE; MINERAL BLOOD LEVEL; MONOTHERAPY; POSTMENOPAUSE; PRIMARY ADRENAL INSUFFICIENCY; PRIORITY JOURNAL; SCORING SYSTEM; SEX DIFFERENCE; URINALYSIS; VITAMIN BLOOD LEVEL; VITAMIN SUPPLEMENTATION; WARD REGION; Z SCORE;

ABSORPTIOMETRY, PHOTON; ADDISON DISEASE; ADRENAL HYPERPLASIA, CONGENITAL; ADULT; AGED; BONE DENSITY; CROSS-SECTIONAL STUDIES; DEXAMETHASONE; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; FEMALE; FEMUR NECK; GLUCOCORTICOIDS; HORMONE REPLACEMENT THERAPY; HUMANS; MALE; MIDDLE AGED; OSTEOPOROSIS; PREDNISOLONE;

EID: 84855479400     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2011-2036     Document Type: Article

References (35)

1. Merke DP, Bornstein SR 2005 Congenital adrenal hyperplasia. Lancet 365:2125-2136 (Pubitemid 40826971)
2. Arlt W, Allolio B 2003 Adrenal insufficiency. Lancet 361:1881-1893 (Pubitemid 36645187)
3. Crown A, Lightman S 2005 Why is the management of glucocorticoid deficiency still controversial: a review of the literature. Clin Endocrinol (Oxf) 63:483-492 (Pubitemid 41626741)
4. Esteban NV, Loughlin T, Yergey AL, Zawadzki JK, Booth JD, Winterer JC, Loriaux DL 1991 Daily cortisol production rate in man determined by stable isotope dilution/mass spectrometry. J Clin Endocrinol Metab 72:39-45 (Pubitemid 21921653)
5. Kerrigan JR, Veldhuis JD, Leyo SA, Iranmanesh A, Rogol AD 1993 Estimation of daily cortisol production and clearance rates in normal pubertal males by deconvolution analysis. J Clin Endocrinol Metab 76:1505-1510 (Pubitemid 23164369)
6. Raisz LG, Kream BE 1983 Regulation of bone formation. N Engl J Med 309:29-35
7. Hahn TJ, Halstead LR, Baran DT 1981 Effects of short term glucocorticoid administration on intestinal calcium absorption and circulating vitamin D metabolite concentrations in man. J Clin Endocrinol Metab 52:111-115 (Pubitemid 11217850)
8. Canalis E, Mazziotti G, Giustina A, Bilezikian JP 2007 Glucocorticoid- induced osteoporosis: pathophysiology and therapy. Osteoporos Int 18:1319-1328 (Pubitemid 47389469)
9. Heureux F, Maiter D, Boutsen Y, Devogelaer JP, Jamart J, Donckier J 2000 Evaluation of corticosteroid replacement therapy and its effect on bones in Addison's disease. Ann Endocrinol (Paris) 61: 179-183
10. Devogelaer JP, Crabbé J, Nagant de Deuxchaisnes C 1987 Bone mineral density in Addison's disease: evidence for an effect of adrenal androgens on bone mass. BrMedJ (Clin Res Ed) 294:798-800 (Pubitemid 17050879)
11. Valero MA, Leon M, Ruiz Valdepeñas MP, Larrodera L, LopezMB, Papapietro K, Jara A, Hawkins F 1994 Bone density and turnover in Addison's disease: effect of glucocorticoid treatment. Bone Miner 26:9-17
12. Zelissen PM, Croughs RJ, van Rijk PP, Raymakers JA 1994 Effect of glucocorticoid replacement therapy on bone mineral density in patients with Addison disease. Ann Intern Med 120:207-210 (Pubitemid 24038804)
13. Braatvedt GD, Joyce M, Evans M, Clearwater J, Reid IR 1999 Bone mineral density in patients with treated Addison's disease. Osteoporos Int 10:435-440 (Pubitemid 30029008)
14. Jódar E, Valdepeñas MP, Martinez G, Jara A, Hawkins F 2003 Long-term follow-up of bone mineral density in Addison's disease. Clin Endocrinol (Oxf) 58:617-620
15. Arlt W, Rosenthal C, Hahner S, Allolio B 2006 Quality of glucocorticoid replacement in adrenal insufficiency: clinical assessment vs. timed serum cortisol measurements. Clin Endocrinol (Oxf) 64: 384-389
16. Løvås K, Gjesdal CG, Christensen M, Wolff AB, Almås B, Svartberg J, Fougner KJ, Syversen U, Bollerslev J, Falch JA,HuntPJ, Chatterjee VK, Husebye ES 2009 Glucocorticoid replacement therapy and pharmacogenetics in Addison's disease: effects on bone. Eur J Endocrinol 160:993-1002
17. Guo CY, Weetman AP, Eastell R 1996 Bone turnover and bone mineral density in patients with congenital adrenal hyperplasia. Clin Endocrinol (Oxf) 45:535-541 (Pubitemid 26411353)
18. Gussinyé M, Carrascosa A, Potau N, Enrubia M, Vicens-Calvet E, Ibáñez L, Yeste D 1997 Bone mineral density in prepubertal and in adolescent and young adult patients with the salt-wasting form of congenital adrenal hyperplasia. Pediatrics 100:671-674 (Pubitemid 27425992)
19. Mora S, Saggion F, Russo G, Weber G, Bellini A, Prinster C, Chiumello G 1996 Bone density in young patients with congenital adrenal hyperplasia. Bone 18:337-340 (Pubitemid 26149345)
20. Stikkelbroeck NM, Oyen WJ, van der Wilt GJ, Hermus AR, Otten BJ 2003 Normal bone mineral density and lean body mass, but increased fat mass, in young adult patients with congenital adrenal hyperplasia. J Clin Endocrinol Metab 88:1036-1042 (Pubitemid 36337753)
21. Girgis R, Winter JS 1997 The effects of glucocorticoid replacement therapy on growth, bone mineral density, and bone turnover markers in children with congenital adrenal hyperplasia. J Clin Endocrinol Metab 82:3926-3929 (Pubitemid 27525488)
22. Christiansen P, Mølgaard C, Müller J 2004 Normal bone mineral content in young adults with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Horm Res 61:133-136 (Pubitemid 38328000)
23. Jääskeläinen J, Voutilainen R 1996 Bone mineral density in relation to glucocorticoid substitution therapy in adult patients with 21- hydroxylase deficiency. Clin Endocrinol (Oxf) 45:707-713 (Pubitemid 27032316)
24. Hagenfeldt K, Martin Ritzén E, Ringertz H, Helleday J, Carlström K 2000 Bone mass and body composition of adult women with congenital virilizing 21-hydroxylase deficiency after glucocorticoid treatment since infancy. Eur J Endocrinol 143:667-671
25. Cameron FJ, Kaymakci B, Byrt EA, Ebeling PR, Warne GL, Wark JD 1995 Bone mineral density and body composition in congenital adrenal hyperplasia. J Clin Endocrinol Metab 80:2238-2243
26. Paganini C, Radetti G, Livieri C, Braga V, Migliavacca D, Adami S 2000 Height, bone mineral density and bone markers in congenital adrenal hyperplasia. Horm Res 54:164-168
27. de Almeida Freire PO, de Lemos-Marini SH, Maciel-Guerra AT, Morcillo AM, Matias Baptista MT, de Mello MP, Guerra Jr G 2003 Classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency: a cross-sectional study of factors involved in bone mineral density. J Bone Miner Metab 21:396-401 (Pubitemid 38017696)
28. King JA, Wisniewski AB, Bankowski BJ, Carson KA, Zacur HA, Migeon CJ 2006 Long-term corticosteroid replacement and bone mineral density in adult women with classical congenital adrenal hyperplasia. J Clin Endocrinol Metab 91:865-869 (Pubitemid 43357751)
29. Sciannamblo M, Russo G, Cuccato D, Chiumello G, Mora S 2006 Reduced bone mineral density and increased bone metabolism rate in young adult patients with 21-hydroxylase deficiency. J Clin Endocrinol Metab 91:4453-4458 (Pubitemid 44833422)
30. Bachelot A, Plu-Bureau G, Thibaud E, Laborde K, Pinto G, Samara D, Nihoul-Fékété C, Kuttenn F, Polak M, Touraine P 2007 Longterm outcome of patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Horm Res 67:268-276 (Pubitemid 46701492)
31. Falhammar H, Filipsson H, Holmdahl G, Janson PO, Nordenskjöld A, Hagenfeldt K, Thorén M 2007 Fractures and bone mineral density in adult women with 21-hydroxylase deficiency. J Clin Endocrinol Metab 92:4643-4649 (Pubitemid 350223439)
32. Zimmermann A, Sido PG, Schulze E, Al Khzouz C, Lazea C, Coldea C, Weber MM 2009 Bone mineral density and bone turnover in Romanian children and young adults with classical 21-hydroxylase deficiency are influenced by glucocorticoid replacement therapy. Clin Endocrinol (Oxf) 71:477-484
33. Rivkees SA, Crawford JD 2000 Dexamethasone treatment of virilizing congenital adrenal hyperplasia: the ability to achieve normal growth. Pediatrics 106:767-773
34. Bleicken B, Hahner S, Loeffler M, Ventz M, Allolio B, Quinkler M 2008 Impaired subjective health status in chronic adrenal insufficiency: impact of different glucocorticoid replacement regimens. Eur J Endocrinol 159:811-817
35. Gurnell EM, Hunt PJ, Curran SE, Conway CL, Pullenayegum EM, Huppert FA, Compston JE, Herbert J, Chatterjee VK 2008 Longterm DHEA replacement in primary adrenal insufficiency: a randomized, controlled trial. J Clin Endocrinol Metab 93:400-409 (Pubitemid 351240809)